SELECTA BIOSCIENCES

selecta-biosciences-logo

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles. It was founded in 2008 and is headquartered in Watertown, Massachusetts.
#People #Financial #Event #Website #More

SELECTA BIOSCIENCES

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biopharma Biotechnology Pharmaceutical

Founded:
2008-01-01

Address:
Watertown, Massachusetts, United States

Country:
United States

Website Url:
http://www.selectabio.com

Total Employee:
51+

Status:
Active

Contact:
(617) 923-1400

Email Addresses:
[email protected]

Total Funding:
320.29 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Domain Not Resolving Wordpress Plugins Nginx



Current Advisors List

amir-nashat_image

Amir Nashat Member of the Board of Directors @ Selecta Biosciences
Board_member
2008-01-01

aymeric-sallin_image

Aymeric Sallin Board Member @ Selecta Biosciences
Board_member

carl-l-gordon_image

Carl L. Gordon Board of Directors @ Selecta Biosciences
Board_member

douglas-cole_image

Douglas Cole Member of the Board of Directors @ Selecta Biosciences
Board_member

yuri-udaltsov_image

Yuri Udaltsov Member of the Board of Directors @ Selecta Biosciences
Board_member

peter-hutt_image

Peter Hutt Member of the Board of Directors @ Selecta Biosciences
Board_member

edwin-kania_image

Edwin Kania Member of the Board of Directors @ Selecta Biosciences
Board_member

george-siber_image

George Siber Board of Directors @ Selecta Biosciences
Board_member

Current Employees Featured

david-abraham_image

David Abraham
David Abraham General Counsel and Corporate Secretary @ Selecta Biosciences
General Counsel and Corporate Secretary

not_available_image

Kevin Tan
Kevin Tan CFO @ Selecta Biosciences
CFO
2021-01-01

lloyd-johnston_image

Lloyd Johnston
Lloyd Johnston Chief Operating Officer and Senior Vice President R&D @ Selecta Biosciences
Chief Operating Officer and Senior Vice President R&D
2014-01-01

takashi-kei-kishimoto_image

Takashi Kei Kishimoto
Takashi Kei Kishimoto Chief Scientific Officer @ Selecta Biosciences
Chief Scientific Officer

wes-dehaan_image

Wes DeHaan
Wes DeHaan Vice President Program Management @ Selecta Biosciences
Vice President Program Management
2017-01-01

nishan-de-silva_image

Nishan de Silva
Nishan de Silva Director @ Selecta Biosciences
Director
2021-06-01

peter-keller_image

Peter Keller
Peter Keller Chief Business Officer @ Selecta Biosciences
Chief Business Officer

peter-g-traber_image

Peter G. Traber
Peter G. Traber Chief Medical Officer @ Selecta Biosciences
Chief Medical Officer
2020-08-01

omid-farokhzad_image

Omid Farokhzad
Omid Farokhzad Founder, Board of Directors and Vice Chairman on the Board @ Selecta Biosciences
Founder, Board of Directors and Vice Chairman on the Board
2008-01-01

Founder


omid-farokhzad_image

Omid Farokhzad

Stock Details


Company's stock symbol is NASDAQ:SELB

Investors List

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Debt - Selecta Biosciences

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Debt - Selecta Biosciences

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Post-IPO Equity - Selecta Biosciences

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series E - Selecta Biosciences

sanofi-genzyme-bioventures_image

Sanofi Ventures

Sanofi Ventures investment in Series E - Selecta Biosciences

sphera-funds-management_image

Sphera Funds Management

Sphera Funds Management investment in Series E - Selecta Biosciences

eminent-venture-capital_image

Eminent Venture Capital

Eminent Venture Capital investment in Series E - Selecta Biosciences

osage-university-partners_image

OUP (Osage University Partners)

OUP (Osage University Partners) investment in Series E - Selecta Biosciences

leukon-investments_image

Leukon Investments

Leukon Investments investment in Series E - Selecta Biosciences

i2bf-global-ventures_image

I2BF Global Ventures

I2BF Global Ventures investment in Series E - Selecta Biosciences

Investments List

Date Company Article Money raised
2021-12-06 Cyrus Biotechnology Selecta Biosciences investment in Series B - Cyrus Biotechnology 18 M USD

Official Site Inspections

http://www.selectabio.com Semrush global rank: 4.76 M Semrush visits lastest month: 1.95 K

  • Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
  • IP address: 15.197.142.173
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Selecta Biosciences" on Search Engine

dfkcompany.com © 2022. All rights reserved